Development of an EEG Diagnostic for Alzheimer's Disease
NCT04954183 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29
Last updated 2025-09-25
Summary
The purpose of this research is to collect and compare electroencephalogram data from all stages of Alzheimer's disease from preclinical through severe dementia.
Conditions
- Mild Cognitive Impairment
- Alzheimer Disease
- Dementia With Lewy Bodies
- Normal Control APOE e4 Carriers and Noncarriers
Sponsors & Collaborators
-
Spark Neuro Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Erik K. St. Louis, MD · Mayo Clinic
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-01
- Primary Completion
- 2025-07-24
- Completion
- 2025-07-24
Countries
- United States
Study Locations
More Related Trials
-
Diagnostic Evaluation of Dementia with Lewy Bodies Using a Multimodal Approach
NCT06068361 ·Status: RECRUITING
-
Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders
NCT00001362 ·Status: COMPLETED
-
Novel Dementia Biomarkers
NCT04427436 ·Status: UNKNOWN
-
Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers
NCT05358431 ·Status: RECRUITING ·Phase: NA
-
The Role of Ophthalmologic Tests and EEG Imaging in Alzheimer's Disease
NCT04277767 ·Status: UNKNOWN
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
A Study of Alzheimer's Disease Using Magnetoencephalography (MEG) and the Synchronous Neural Interaction™ Test
NCT01322373 ·Status: UNKNOWN
-
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
NCT04680130 ·Status: ENROLLING_BY_INVITATION
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
New Biomarker for Alzheimer's Disease Diagnostic
NCT01315639 ·Status: COMPLETED ·Phase: NA
-
Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
NCT00973518 ·Status: COMPLETED
-
A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)
NCT00757939 ·Status: COMPLETED ·Phase: PHASE1
-
Amyloid Plaque and Tangle Imaging in Aging and Dementia
NCT00355498 ·Status: COMPLETED
-
New CSF Biomarkers for Alzheimer's Disease
NCT03621839 ·Status: RECRUITING
-
Amyloid Beta-peptide 1-40 and Alzheimer's Disease
NCT02770482 ·Status: COMPLETED ·Phase: NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
NCT03225144 ·Status: RECRUITING
-
Neuro Imaging and Multimodal Alzheimer's Disease
NCT02839187 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease
NCT06057909 ·Status: RECRUITING
-
Brain Connectivity Marker for Alzheimer's Disease
NCT06874231 ·Status: RECRUITING
-
Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
NCT01876459 ·Status: UNKNOWN ·Phase: NA
-
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
NCT02740634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
NCT00582127 ·Status: COMPLETED
-
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
NCT07089303 ·Status: RECRUITING
-
MR Elastography of Cognitive Impairment
NCT06029114 ·Status: ENROLLING_BY_INVITATION